SCHEMBL880118

SCHEMBL880118

COBNCC(O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 9/20 0.62
ROCK2 O75116 7/20 0.62
AKT2 P31751 5/20 0.62
PRKACA P17612 2/20 0.62
AKT3 Q9Y243 2/20 0.62
PRKCD Q05655 2/20 0.62
RPS6KA5 O75582 1/20 0.62
RPS6KA4 O75676 1/20 0.62
LATS1 O95835 1/20 0.62
PRKACB P22694 1/20 0.62
RPS6KB1 P23443 1/20 0.62
GRK2 P25098 1/20 0.62
RPS6KA3 P51812 1/20 0.62
ROCK1 Q13464 1/20 0.62
RPS6KA2 Q15349 1/20 0.62
RPS6KA1 Q15418 1/20 0.62
PKN1 Q16512 1/20 0.62
PKN2 Q16513 1/20 0.62
SGK3 Q96BR1 1/20 0.62
RPS6KB2 Q9UBS0 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979179 0.84 AKT1 (0.70) AKT1ROCK2AKT2PRKACAAKT3
SCHEMBL13327376 0.80 AKT1 (0.64) AKT1ROCK2AKT2PRKACAAKT3
SCHEMBL3024761 0.78 AKT1 (0.80) AKT1ROCK2AKT2PRKACAAKT3
SCHEMBL3025820 0.78 AKT1 (0.80) AKT1ROCK2AKT2PRKACAAKT3
SCHEMBL3028412 0.78 AKT1 (0.80) AKT1ROCK2AKT2PRKACAAKT3
At-13148 SCHEMBL850592 0.77 AKT1 (1.00) AKT1ROCK2AKT2PRKACAAKT3
SCHEMBL880116 0.77 NPSR1 (0.49) AKT1AKT2PRKACAAKT3NPSR1
At-13148 SCHEMBL851075 0.77 AKT1 (1.00) AKT1ROCK2AKT2PRKACAAKT3
At-13148 SCHEMBL851471 0.77 AKT1 (1.00) AKT1ROCK2AKT2PRKACAAKT3
SCHEMBL3020349 0.77 AKT1 (0.67) AKT1ROCK2AKT2PRKACAAKT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2433632-A1 Compositions and combinations comprising non-racemic 2-amino-1-(4-chloro-phenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol, for use in medicine Astex Therapeutics Limited (GB) 2012-03-28 EP disclosed
WO-2008110846-A2 COMPOSITIONS COMPRISING (S)-2-AMINO-1-(4-CHLOROPHENYL)-1-[4-(1H-PYRAZOL-4-YL)-PHENYL]-ETHANOL AS MODULATOR OF PROTEIN KINASES ASTEX THERAPEUTICS LIMITED (GB) 2008-09-18 WO disclosed